$49.59
-0.28-0.56%
At Close: -
$50.00
0.410.83%
After Hours: 6:11 PM EDT
15 minutes delayed
Comments
Loading...
CRISPR Therapeutics (CRSP) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestCRISPR Therapeutics (NASDAQ:CRSP) Stock Quotes, Forecast and News Summary
CRISPR Therapeutics Stock (NASDAQ: CRSP) stock price, news, charts, stock research, profile.
| Open | $50.00 |
| Close | $49.59 |
| Volume / Avg. | 1.69M / 1.23M |
| Day Range | $49.18 - $51.99 |
| 52 Wk Range | 37.55 - 91.10 |
| Market Cap | $4.26B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 56 |
| Short Interest | 23.21% |
| Days to Cover | 19.97 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About
Sector
Healthcare
Industry
N/A
Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therap...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy CRISPR Therapeutics (CRSP) stock?
You can purchase shares of CRISPR Therapeutics (NASDAQ:CRSP) through any online brokerage.
Who are CRISPR Therapeutics (CRSP) competitors?
There are no as such competitors for CRISPR Therapeutics.
What is the forecast, or price target, for CRISPR Therapeutics (CRSP) stock?
CRISPR Therapeutics has a consensus price target of $74.40.
What is the current price for CRISPR Therapeutics (CRSP)?
The stock price for CRISPR Therapeutics (NASDAQ: CRSP) is $50 last updated September 18, 2024 at 6:11 PM EDT.
Does CRISPR Therapeutics (CRSP) pay a dividend?
There are no upcoming dividends for CRISPR Therapeutics.
When is CRISPR Therapeutics (NASDAQ:CRSP) reporting earnings?
CRISPR Therapeutics’s Q3 earnings are confirmed for Monday, November 4, 2024.
Is CRISPR Therapeutics (CRSP) going to split?
There is no upcoming split for CRISPR Therapeutics.
What sector and industry does CRISPR Therapeutics (CRSP) operate in?
CRISPR Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.